ES2062921B1 - 3-(indol-2-carboxiamido)quinuclidinas. - Google Patents

3-(indol-2-carboxiamido)quinuclidinas.

Info

Publication number
ES2062921B1
ES2062921B1 ES9202252A ES9202252A ES2062921B1 ES 2062921 B1 ES2062921 B1 ES 2062921B1 ES 9202252 A ES9202252 A ES 9202252A ES 9202252 A ES9202252 A ES 9202252A ES 2062921 B1 ES2062921 B1 ES 2062921B1
Authority
ES
Spain
Prior art keywords
carboxiamido
quinuclidines
indol
ind
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES9202252A
Other languages
English (en)
Other versions
ES2062921A1 (es
Inventor
Henning Boettcher
Cristoph Seyfried
Gerd Bartoszyk
Klaus-Otto Minck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Priority to ES9202252A priority Critical patent/ES2062921B1/es
Publication of ES2062921A1 publication Critical patent/ES2062921A1/es
Application granted granted Critical
Publication of ES2062921B1 publication Critical patent/ES2062921B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

3-(INDOL-2-CARBOXIAMIDO)QUINUCLIDINAS DE LA FORMULA I IND-CO-NHR: I, EN LAS QUE IND ES UN GRUPO 2-INDOLILO QUE ESTA INSUBSTITUIDO O DE MONO A TRISUBSTITUIDO POR ALQUILO, ALCOXI, ALCOXICARBONILO Y/O ALQUILTIO CON EN CADA CASO 1-5 ATOMOS DE C, ARALQUILOXI DE 7-11 C, ACILOXI DE 1-5 C, AROILOXI DE 6-10 C, TRIFLUOROMETILO, CIANO, FLUOR, CLORO, HIDROXILO, ALQUILSULFONILOXI DE 1-4 C, ARILSULFONILOXI DE 6-10 C, CARBOXILO Y/OMETILENDIOXI Y R ES 3-QUINUCLIDINILO Y SUS SALES FISIOLOGICAMENTE ACEPTABLES QUE MUESTRAN UN EFECTO ANTAGONISTA HACIA LA SEROTONINA Y PUEDEN USARSE COMO PSICOFARMACOS.
ES9202252A 1992-11-06 1992-11-06 3-(indol-2-carboxiamido)quinuclidinas. Expired - Lifetime ES2062921B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9202252A ES2062921B1 (es) 1992-11-06 1992-11-06 3-(indol-2-carboxiamido)quinuclidinas.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9202252A ES2062921B1 (es) 1992-11-06 1992-11-06 3-(indol-2-carboxiamido)quinuclidinas.

Publications (2)

Publication Number Publication Date
ES2062921A1 ES2062921A1 (es) 1994-12-16
ES2062921B1 true ES2062921B1 (es) 1995-06-16

Family

ID=8278717

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9202252A Expired - Lifetime ES2062921B1 (es) 1992-11-06 1992-11-06 3-(indol-2-carboxiamido)quinuclidinas.

Country Status (1)

Country Link
ES (1) ES2062921B1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8701682A (nl) * 1986-07-30 1988-02-16 Sandoz Ag Werkwijze voor het therapeutisch toepassen van serotonine antagonisten, aktieve verbindingen en farmaceutische preparaten die deze verbindingen bevatten.
DE3881950T2 (de) * 1987-04-25 1993-09-30 Beecham Group Plc Azabicyclische Verbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
NZ227841A (en) * 1988-02-12 1991-08-27 Merck Sharp & Dohme Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions

Also Published As

Publication number Publication date
ES2062921A1 (es) 1994-12-16

Similar Documents

Publication Publication Date Title
ES2058396T3 (es) N-isopropilanilidas de acido heteroariloxiacetico.
PE108099A1 (es) Acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
ES2053479T3 (es) Hidrorepelente para albañileria.
ES2097782T3 (es) Metodo y composicion para la determinacion de iones sodio en fluidos.
ES2158344T3 (es) Compuestos benzoxazepinicos, su produccion y uso como agentes reductores de lipidos.
AR245700A1 (es) Nuevos derivados de la 2-anilino-pirimidina como agentes antiparasitarios.
YU47204B (sh) Derivati didehidro-vitamina d3
ES2162198T3 (es) Agentes estrogenos.
NO952399L (no) Pyrazolopyrimidiner som CRF antagonister
ATE440615T1 (de) Verwendung von methioninase als antitumormittel in der antimethionin-chemotherapie
ES2115838T3 (es) Procedimiento para la purificacion de acido (met)acrilico en bruto.
ES2168766T3 (es) Preparacion farmaceutica que incluye el propeptido vwf.
UY24563A1 (es) Análogos fluorinados de la vitamina d3
ES2030013T3 (es) Procedimiento para producir un nuevo compuesto que tiene base de hipoxantina.
ES8105265A1 (es) Un procedimiento para la preparacion de fenetanolaminas
ES2058191T3 (es) Acidos 2-fenil-4-quinolincarboxilicos substituidos.
BR9916167A (pt) Tucho de rolamento
DK1274414T3 (da) Nasal administration af Metocloropramid til behandling af Gastroparese
ES2145563T3 (es) Nuevos derivados de la imidazolina con una afinidad para los receptores imidazolinicos.
ES2062921B1 (es) 3-(indol-2-carboxiamido)quinuclidinas.
BR0213317A (pt) Uso de um composto, método de tratar um distúrbio relacionado com gastrina, composição farmacêutica, kit, usos de uma composição, e de um inibidor de bomba de próton, métodos de preparar uma composição farmacêutica e um composto, e, composto
PE15196A1 (es) Compuesto de di-tert-butifenol util como agente antiinflamatorio
ES2144768T3 (es) Derivados de bases esfingoides basados en retinoil-amida.
ES2166838T3 (es) 6-(triazolil(3-(trifluorometil)fenil)metil)-2-quinolinonas y -quinolinationas.
NO984245L (no) Nasal administrasjon av midler for behandling av emesis med forsinket begynnelse

Legal Events

Date Code Title Description
FA2A Application withdrawn

Effective date: 19960115